Navigation Links
Cancer Drug Safe for Late-Stage Pelvic Disease
Date:4/7/2010

Vorinostat can be used with radiotherapy in palliative care, study finds

WEDNESDAY, April 7 (HealthDay News) -- It's safe to use a new oral anti-cancer drug called vorinostat with short-term palliative radiation therapy in patients with advanced pelvic cancer, according to a phase 1 study.

Palliative therapy is used to help control symptoms in patients who can't be cured.

Radiation therapy is an effective palliative treatment to control pain and bleeding in patients with advanced pelvic cancer who aren't eligible for curative radiation therapy or surgery. Vorinostat -- a type of histone deacetylase (HDAC) inhibitor -- is believed to stop tumor growth by altering the expression of several genes necessary for cancer growth.

This study included 16 patients who received either 100 milligram, 200 mg, 300 mg, or 400 mg daily doses of vorinostat three hours before pelvic palliative radiation to 30 Gy in 3 Gy daily fractions over two weeks.

Nausea, diarrhea and anorexia were the most common side effects experienced by all the patients. Biological activity of vorinostat was detected in patients who received the lowest and highest levels of the drug. Most patients had an overall decrease in tumor size six weeks after they completed the combined treatment.

"These observations show that vorinostat can be safely combined with a standard palliative radiotherapy regimen to treat advanced pelvic cancer," wrote Prof. Anne H. Ree of Norwegian Radium Hospital in Oslo and colleagues.

"This study adds to mounting evidence supporting the use of HDAC inhibition in cancer therapy. These data encourage further examination of this class of molecularly targeted agents in clinical radiotherapy," they concluded.

The study was published online April 6 in The Lancet Oncology.

More information

The U.S. National Institutes of Health has more on palliative care.



-- Robert Preidt



SOURCE: The Lancet Oncology, news release, April 6, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New study implicates health care utilization, over biology, in colorectal cancer disparities
2. Mount Sinai study finds only a weak link between fruit and vegetable and reduced risk of cancer
3. Fruits, Veggies Have Modest Effect on Cancer Risk
4. Gene Mutations Up Risk for Cancer in Opposite Breast
5. Childhood cancer survivors may face shortened lifespan, study reveals
6. New pyrimidine compounds may lead to improved treatments for childhood brain cancer
7. Breast cancer patients with BRCA mutations 4 times more likely to get cancer in opposite breast
8. Childhood Cancer Survivors At Higher Odds of Early Death
9. Only women with Western Swedish breast cancer gene run higher risk of ovarian cancer
10. New investigation supports correlation between XMRV and prostate cancer
11. New Breast Cancer Book Offers Humor Filled Look at Being Thirty-Something, Single And Getting Through Diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric ... in their patients. Research shows that the Goal Attainment Scale (GAS) captures 20% ... this challenge and learn more about the Goal Attainment Scale, Education Resources Inc. ...
(Date:2/10/2016)... ... 2016 , ... A national ergonomics pioneer , HealthPostures, ... March 9-11, 2016. Hosted by Ohio's Bureau of Worker's Compensation, the expo will ... running and largest worker's compensation event in Ohio, organizers of the safety congress ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has ... readily available to physicians. The integration will enable Allscripts users to post ... via Everseat’s free mobile app. , The partnership gives Everseat substantial added power ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... UNF Drive, Jacksonville, FL 32224, February 26th: Amateur & Professional Divisions - ... - Time: 7:00pm – 10:00pm | Ticket Prices $30, Social Media: ...
(Date:2/10/2016)... CA (PRWEB) , ... February 10, 2016 , ... Workrite ... based company that has evolved from humble beginnings to being an internationally recognized leader ... company that we are today”, said Charlie Lawrence, President of Workrite. “Workrite recognized ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Feb. 10, 2016 CSI Specialty Group (CSI) ... launch of the Specialty Pharmacy Podcast. A free, weekly ... at providing real-world education, discussion and context amongst specialty ... --> The Specialty Pharmacy Podcast, ... CSI Specialty Group Suzette DiMascio, CHE, CMCE, CPC, is ...
(Date:2/10/2016)... MINNEAPOLIS , Feb. 10, 2016 Urologix, ... for the treatment of Benign Prostatic Hyperplasia (BPH), announces ... Ash Keswani , a medical device industry veteran ... of the Limited Liability Company.  ... and service lines, Cooled ThermoTherapy™ and Prostiva® RF Therapy, ...
(Date:2/10/2016)... Feb. 10, 2016  Oxis International Inc. (OTC/QB: OXIS) ... was described as a "clinical trial triumph" after one ... into complete cancer remission. Daniel Vallera ... Masonic Cancer Center. --> Daniel Vallera ... Masonic Cancer Center. --> An article ...
Breaking Medicine Technology: